Abstract A004: Tertiary lymphoid structures drive early response to combined anti-angiogenic and immune checkpoint therapy in recurrent ovarian cancer: A biomarker discovery study
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: Centre Hospitalier Universitaire Vaudois
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414349209
Cites:
Cited by:
Related to:
